Guggenheim Capital’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4,266
| Closed | -$254K | – | 1896 |
|
|
2023
Q2 | $254K | Sell |
4,266
-3,066
| -42% | -$183K | ﹤0.01% | 1710 |
|
|
2023
Q1 | $459K | Sell |
7,332
-9,100
| -55% | -$568K | ﹤0.01% | 1522 |
|
|
2022
Q4 | $1.03M | Sell |
16,432
-94
| -0.6% | -$5.39K | 0.01% | 1148 |
|
|
2022
Q3 | $823K | Sell |
16,526
-5,601
| -25% | -$310K | 0.01% | 1242 |
|
|
2022
Q2 | $1.3M | Buy |
22,127
+6,554
| +42% | +$361K | 0.01% | 1103 |
|
|
2022
Q1 | $824K | Sell |
15,573
-215
| -1% | -$12.4K | 0.01% | 1457 |
|
|
2021
Q4 | $958K | Sell |
15,788
-1,810
| -10% | -$107K | 0.01% | 1392 |
|
|
2021
Q3 | $987K | Sell |
17,598
-2,133
| -11% | -$117K | 0.01% | 1423 |
|
|
2021
Q2 | $1.03M | Buy |
19,731
+7,306
| +59% | +$351K | 0.01% | 1477 |
|
|
2021
Q1 | $548K | Sell |
12,425
-7,518
| -38% | -$316K | ﹤0.01% | 1672 |
|
|
2020
Q4 | $695K | Buy |
19,943
+11,193
| +128% | +$397K | ﹤0.01% | 1502 |
|
|
2020
Q3 | $319K | Buy |
+8,750
| New | +$325K | ﹤0.01% | 1613 |
|
|
2018
Q3 | – | Sell |
-61,402
| Closed | -$2.36M | – | 2407 |
|
|
2018
Q2 | $2.36M | Sell |
61,402
-94,744
| -61% | -$3.19M | 0.02% | 1150 |
|
|
2018
Q1 | $5.26M | Buy |
156,146
+82,593
| +112% | +$3.17M | 0.01% | 987 |
|
|
2017
Q4 | $3.27M | Buy |
73,553
+56,143
| +322% | +$2.56M | 0.01% | 1293 |
|
|
2017
Q3 | $872K | Buy |
17,410
+1,531
| +10% | +$78.2K | ﹤0.01% | 2158 |
|
|
2017
Q2 | $840K | Buy |
15,879
+2,300
| +17% | +$123K | ﹤0.01% | 2169 |
|
|
2017
Q1 | $756K | Sell |
13,579
-1,761
| -11% | -$97.1K | ﹤0.01% | 2245 |
|
|
2016
Q4 | $799K | Sell |
15,340
-144,207
| -90% | -$6.96M | ﹤0.01% | 2251 |
|
|
2016
Q3 | $7.7M | Sell |
159,547
-16,887
| -10% | -$854K | 0.02% | 787 |
|
|
2016
Q2 | $9.78M | Buy |
176,434
+134,684
| +323% | +$7.42M | 0.03% | 671 |
|
|
2016
Q1 | $2.23M | Sell |
41,750
-3,237
| -7% | -$159K | 0.01% | 1491 |
|
|
2015
Q4 | $2.32M | Buy |
44,987
+26,591
| +145% | +$1.32M | 0.01% | 1511 |
|
|
2015
Q3 | $831K | Buy |
18,396
+13,176
| +252% | +$622K | ﹤0.01% | 2195 |
|
|
2015
Q2 | $241K | Sell |
5,220
-105
| -2% | -$4.6K | ﹤0.01% | 2768 |
|
|
2015
Q1 | $228K | Sell |
5,325
-2,632
| -33% | -$100K | ﹤0.01% | 2763 |
|
|
2014
Q4 | $277K | Sell |
7,957
-25,795
| -76% | -$856K | ﹤0.01% | 2708 |
|
|
2014
Q3 | $1.09M | Sell |
33,752
-5,552
| -14% | -$186K | ﹤0.01% | 2183 |
|
|
2014
Q2 | $1.33M | Sell |
39,304
-8,095
| -17% | -$259K | ﹤0.01% | 2100 |
|
|
2014
Q1 | $1.29M | Sell |
47,399
-13,357
| -22% | -$397K | ﹤0.01% | 2098 |
|
|
2013
Q4 | $2.17M | Sell |
60,756
-10,994
| -15% | -$365K | 0.01% | 1714 |
|
|
2013
Q3 | $2.16M | Buy |
71,750
+8,834
| +14% | +$289K | 0.01% | 1562 |
|
|
2013
Q2 | $1.83M | Buy |
+62,916
| New | +$1.77M | 0.01% | 1591 |
|
Other funds holding PBH
AI
WHG
Guggenheim Capital's PBH Position: Q3 2023 in Review
Guggenheim Capital sold out of Prestige Consumer Healthcare (PBH) in Q3 2023, closing a stake of 4,266 shares — an estimated $254K sold.
Guggenheim Capital first reported a position in PBH in Q2 2013 and held it in 33 quarters. The position peaked at $9.78M in Q2 2016. 279 funds tracked by Wall St. Rank hold PBH as of Q3 2023.
- Guggenheim Capital reported no remaining Prestige Consumer Healthcare position as of Q3 2023 after selling out during the quarter.
- Guggenheim Capital sold 4,266 Prestige Consumer Healthcare shares in Q3 2023, an estimated $254K.
- Guggenheim Capital first reported a position in Prestige Consumer Healthcare in Q2 2013 and held it in 33 quarters.
- Guggenheim Capital's Prestige Consumer Healthcare position peaked at $9.78M in Q2 2016.
- 279 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2023.
Based on Guggenheim Capital's 13F filing for Q3 2023, filed 14 Nov 2023.